 | • レポートコード：D0FB0633413 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥435,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥551,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥725,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 個別化癌治療薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は個別化癌治療薬の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける個別化癌治療薬市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・個別化癌治療薬のアジア市場規模推移2014-2019 ・個別化癌治療薬のアジア市場規模予測2019-2024 ・個別化癌治療薬のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（Bayer、GlaxoSmithKline、Novartis、Sanofi、Pfizer、Amgen、Merck、Bristol-Myers Squibb、Celgene Corporation、Ariad Pharmaceuticals、Eli Lilly、Hoffmann-La Roche、Boehringer Ingelheim、Johnson and Johnso） ・結論 |
Abstract:
The Asia Pacific Personalizing Cancer Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.
This report is an essential reference for who looks for detailed information on Asia Pacific Personalizing Cancer Drugs market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Personalizing Cancer Drugs market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.
Key Points of this Report:
* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Personalizing Cancer Drugs
* It describes present situation, historical background and future forecast
* Comprehensive data showing Personalizing Cancer Drugs capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Personalizing Cancer Drugs manufacturers
* Personalizing Cancer Drugs market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us
The largest vendors of Asia Pacific Personalizing Cancer Drugs market: (At least 14 companies included)
* Bayer
* GlaxoSmithKline
* Novartis
* Sanofi
* Pfizer
* Amgen
For complete list, please ask for sample pages.
The Personalizing Cancer Drugs market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand
The reports analysis Personalizing Cancer Drugs market in Asia Pacific by products type:
* Type I
* Type II
* Type III
The reports analysis Personalizing Cancer Drugs market in Asia Pacific by application as well:
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Table of Contents
Chapter One Personalizing Cancer Drugs Overview
1.1 Personalizing Cancer Drugs Outline
1.2 Classification and Application
1.3 Manufacturing Technology
Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis
Chapter Three Market Dynamics of Personalizing Cancer Drugs Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges
Chapter Four Asia Pacific Market of Personalizing Cancer Drugs (2014-2019)
4.1 Personalizing Cancer Drugs Supply
4.2 Personalizing Cancer Drugs Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis
Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Personalizing Cancer Drugs Supply
5.2 Personalizing Cancer Drugs Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis
Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation
Chapter Seven Asia Pacific Personalizing Cancer Drugs Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis
Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Bayer
8.2 GlaxoSmithKline
8.3 Novartis
8.4 Sanofi
8.5 Pfizer
……
……
Chapter Nine Research Conclusions of Asia Pacific Personalizing Cancer Drugs Industry
Tables and Figures
Figure Commercial Product of Personalizing Cancer Drugs
Table Classification of Personalizing Cancer Drugs
Table Application of Personalizing Cancer Drugs
Figure Porter Five Forces Model Analysis of Asia Pacific Personalizing Cancer Drugs
Figure Production Cost Analysis of Asia Pacific Personalizing Cancer Drugs
Table Personalizing Cancer Drugs Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Capacity List
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production List
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Production Value and Growth Rate
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Personalizing Cancer Drugs
Table 2014-2019 Asia Pacific Import and Export of Personalizing Cancer Drugs
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Demand List by Application
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Demand by Application
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Demand Share List by Application
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Demand Share by Application
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption List
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption Share
Table 2014-2019 Asia Pacific Personalizing Cancer Drugs Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Capacity List
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production List
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Personalizing Cancer Drugs
Table 2019-2024 Asia Pacific Import and Export of Personalizing Cancer Drugs
Table 2019-2024 Asia Pacific Demand of Personalizing Cancer Drugs by Application
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Demand by Application
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Demand Share List by Application
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Demand Share by Application
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption List
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Personalizing Cancer Drugs Country-wise Consumption Share
Table 2019-2024 Asia Pacific Personalizing Cancer Drugs Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Personalizing Cancer Drugs Raw Material Suppliers
Table Key End Users List
Table Profile of Bayer
Table SWOT Analysis of Bayer
Table Bayer Personalizing Cancer Drugs Product Specification
Table 2014-2019 Bayer Personalizing Cancer Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Bayer Personalizing Cancer Drugs Capacity Production and Growth Rate
Figure 2014-2019 Bayer Personalizing Cancer Drugs Production Global Market Share
Table SWOT Analysis of GlaxoSmithKline
Figure GlaxoSmithKline Personalizing Cancer Drugs Products
Table 2014-2019 GlaxoSmithKline Personalizing Cancer Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 GlaxoSmithKline Personalizing Cancer Drugs Capacity Production and Growth Rate
Figure 2014-2019 GlaxoSmithKline Personalizing Cancer Drugs Production Global Market Share
Table SWOT Analysis of Novartis
Figure Novartis Personalizing Cancer Drugs Product
Table Novartis Personalizing Cancer Drugs Product Specification
Table 2014-2019 Novartis Personalizing Cancer Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Novartis Personalizing Cancer Drugs Capacity Production and Growth Rate
Figure 2014-2019 Novartis Personalizing Cancer Drugs Production Global Market Share
Table Profile of Sanofi
Table SWOT Analysis of Sanofi
Figure Sanofi Personalizing Cancer Drugs Product
Table Sanofi Personalizing Cancer Drugs Product Specification
Table 2014-2019 Sanofi Personalizing Cancer Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Sanofi Personalizing Cancer Drugs Capacity Production and Growth Rate
Figure 2014-2019 Sanofi Personalizing Cancer Drugs Production Global Market Share
Table Profile of Pfizer
Table SWOT Analysis of Pfizer
Figure Pfizer Personalizing Cancer Drugs Product
Table 2014-2019 Pfizer Personalizing Cancer Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Pfizer Personalizing Cancer Drugs Capacity Production and Growth Rate
Figure 2014-2019 Pfizer Personalizing Cancer Drugs Production Global Market Share
……
……
血液癌治療薬のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Blood Cancer Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on As…- 癌治療薬のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Cancer Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on Asia Pac…
- 標的癌薬のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Targeted Cancer Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on…
- 肝癌治療薬のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Liver Cancer Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on As…
- 腎臓/腎癌薬のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Kidney/Renal Cancer Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed informatio…